The FDA will allow genetic testing company 23andMe to market personal genome reports as a direct-to-consumer test of a person’s ability to metabolize some medications to help inform discussions with healthcare providers.
A large chunk of the American population doesn’t know when the open enrollment period is to purchase healthcare insurance, according to a recent study by insuranceQuotes. And recent political moves have contributed to confusion among Americans.
As the state of New York considers the pending $69 billion merger between retail pharmacy chain CVS Health and health insurance giant Aetna, CVS’ practices in drug pricing are coming under the microscope.
While many GOP leaders have demonized a Medicare for all policy popularized by Sen. Bernie Sanders (I-VT), many Republicans are actually supportive of such a proposal, according to a recent poll by HillTV and the HarrisX polling company.
Industry groups have submitted their final comments on CMS’ recent proposal to overhaul the Medicare Shared Savings Program, warning that some of the new changes could result in fewer accountable care organizations participating in the program.
As Canada is set to legalize marijuana use on Oct. 17, Walmart—the world’s largest employer—is seriously considering adding cannabis products alongside other medications in its aisles in the country, according to Hemp Industry Daily.